T.J. Schaefer
Analyst · Ben Klieve from Lake Street Capital Markets. Your line is now open
Thank you, Stan, and good afternoon, everyone. Today, I will walk you through our third quarter financial highlights. In my prepared remarks, we’ll focus on our results from continuing operations, which excludes all body care related results for the period discussed. So let me spend just a few minutes providing some background as to why these brands are now being presented as discontinued operations. As you recall, we exited the Body Care co-packing business in the first half of 2022 and then made the decision to license the Savvy Naturals brand to Radian’s Beauty in July of 2022. At that time, we also ceased body care manufacturing activities and began using third-party manufacturers for ProVault and SoulSpring in an effort to simplify our business, focus our resources and increase our margins while freeing up cash. We considered GoodWheat, Zola and ProVault to be core brands that could offer attractive margins, provide differentiation and give us the ability to scale. However, the CBD category continued to face challenges that included one, a lack of distribution opportunities as the majority of U.S. retailers would not take CBD products, including online retailers, such as Amazon. Two, many retailers that did sell CBD put the product behind locked glass doors that had a negative impact on sales. Three, CBD products could not be marketed on large mainstream platforms such as Google Search, Facebook and Instagram, limiting our ability to advertise. And four, many retailers that once sold CBD made the decision to significantly reduce or completely step out of the category. As a result, we began to explore strategic alternatives for ProVault and SoulSpring at the beginning of 2023, but we’re unable to find a buyer. In June of 2023, we notified retailers that we would no longer be producing the product. And in September 2023, we stopped selling both brands. Given the strategic shift as well as the meaningful impact that all of these brands had on our prior year financial results, we made the decision to classify these businesses as discontinued operations in accordance with the guidance disclosures. Moving now to our results from continuing operations. Revenues of $1.6 million increased 2% year-over-year as higher sales of GoodWheat were largely offset by lost distribution at Zola that occurred at the end of 2022. On a sequential basis, revenues increased 20% in Q3 driven by increased GoodWheat distribution and higher sales of Zola. Gross margins in Q3 2023 were 31% compared to 28% in the prior year, which was in line with our expectations. On a year-to-date basis, our gross margins have increased nearly 1,500 basis points compared to the same period last year. Research and development expenses of $305,000 were $50,000 above prior year, but $86,000 below the prior quarter as a result of innovation work in Q2 2023 that resulted in the launch of Pancakes and Mac & Cheese. Selling, general and administrative expenses of $3.4 million were 18% below prior year and 4% below the prior quarter, primarily driven by lower headcount associated with the Body Care brands, as we discussed last quarter. And as Stan mentioned in his opening remarks, our SG&A expenses are now at the lowest level since 2019. We will continue to evaluate our expense profile in an effort to conserve cash. The reduction in expenses led to a 19% year-over-year improvement in our loss from continuing operations. We recorded $133,000 of interest income as well as a benefit of $608,000 from the change in the fair value of common stock warrant and option liabilities resulting in a net loss attributable to common stockholders of $2.5 million. Our cash and short-term investments at the end of Q3 2023 were $15.7 million a decline of $2.8 million compared to the previous quarter. We expect our use of cash to increase in the fourth quarter, driven by an estimated payment of $1 million related to the grow, out of approximately 6 million pounds of grain that will be used to produce Pasta and Mac & Cheese. Accounts receivable of $304,000 declined by $917,000 compared to the beginning of the year, driven by $1 million in milestone payments from Bioceres. As a reminder, we have now collected all milestone payments related to the Chinese approval of HB4 Soy. Total inventory of $4.3 million is approximately $1.2 million higher than the balance at the beginning of the year with approximately 80% of this inventory attributable to GoodWheat driven by production runs in May and September of 2023. We do not anticipate any production runs until Q2 of next year and plan to sell through our finished goods over the next six months. In conclusion, we are extremely pleased with the progress we have made so far. We have delivered positive gross profit from continuing operations for seven consecutive quarters, have reduced our SG&A expenses to the lowest level in 4 years, lowered our cash burn to less than $3 million in the latest quarter. And we now enter 2024 and with the opportunity to scale three GoodWheat categories and the potential to add additional categories through acquisition. With that, I will now turn the call back over to the operator for questions.